TITLE

Fibroblast growth factor-2 mediates transforming growth factor-β action in prostate cancer reactive stroma

AUTHOR(S)
Yang, F.; Strand, D. W.; Rowley, D. R.
PUB. DATE
January 2008
SOURCE
Oncogene;1/17/2008, Vol. 27 Issue 4, p450
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Transforming growth factor-β (TGF-β) is overexpressed at sites of wound repair and in most adenocarcinomas including prostate cancer. In stromal tissues, TGF-β regulates cell proliferation, phenotype and matrix synthesis. To address mechanisms of TGF-β action in cancer-associated reactive stroma, we developed prostate stromal cells null for TGF-β receptor II (TβRII) or engineered to express a dominant-negative Smad3 to attenuate TGF-β signaling. The differential reactive stroma (DRS) xenograft model was used to evaluate altered stromal TGF-β signaling on LNCaP tumor progression. LNCaP xenograft tumors constructed with TβRII null or dominant-negative Smad3 stromal cells exhibited a significant reduction in mass and microvessel density relative to controls. Additionally, decreased cellular fibroblast growth factor-2 (FGF-2) immunostaining was associated with attenuated TGF-β signaling in stroma. In vitro, TGF-β stimulated stromal FGF-2 expression and release. However, stromal cells with attenuated TGF-β signaling were refractory to TGF-β-stimulated FGF-2 expression and release. Re-expression of FGF-2 in these stromal cells in DRS xenografts resulted in restored tumor mass and microvessel density. In summary, these data show that TGF-β signaling in reactive stroma is angiogenic and tumor promoting and that this effect is mediated in part through a TβRII/Smad3-dependent upregulation of FGF-2 expression and release.Oncogene (2008) 27, 450–459; doi:10.1038/sj.onc.1210663; published online 16 July 2007
ACCESSION #
28438533

 

Related Articles

  • Control of cell proliferation by a porous chitosan scaffold with multiple releasing capabilities. Cai, Shu-Jyun; Li, Ching-Wen; Weihs, Daphne; Wang, Gou-Jen // Science & Technology of Advanced Materials;2017, Vol. 18 Issue 1, p987 

    The aim of this study was to develop a porous chitosan scaffold with long-acting drug release as an artificial dressing to promote skin wound healing. The dressing was fabricated by pre-freezing at different temperatures (−20 and −80 °C) for different periods of time, followed...

  • Expression and Methylation of FGF2, TGF-β and Their Downstream Mediators during Different Developmental Stages of Leg Muscles in Chicken. Lu, Yue; Chen, Sirui; Yang, Ning // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    A number of growth factors determine the proliferation of myoblasts and therefore the number of ultimate myofibers. The members of transforming growth factor-beta (TGF-β) family and the fibroblast growth factor 2 (FGF2) have profound effects on skeletal myoblasts proliferation in various...

  • Role of TGF-β signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells. Datta, Raktima; Halder, Sunil; Zhang, Binhao // Journal of Cancer Research & Clinical Oncology;Apr2013, Vol. 139 Issue 4, p563 

    Purpose: Curcumin has been shown to have potent anticancer activities like inhibition of cell proliferation, induction of apoptosis, and suppression of angiogenesis. Transforming growth factor-β (TGF-β) signaling plays a complex role in tumor suppression and promotion depending on the...

  • A non-Smad mechanism of fibroblast activation by transforming growth factor-β via c-Abl and Egr-1: selective modulation by imatinib mesylate. Bhattacharyya, S.; Ishida, W.; Wu, M.; Wilkes, M.; Mori, Y.; Hinchcliff, M.; Leof, E.; Varga, J. // Oncogene;3/12/2009, Vol. 28 Issue 10, p1285 

    The nonreceptor protein tyrosine kinase c-Abl regulates cell proliferation and survival. Recent studies provide evidence that implicate c-Abl as a mediator for fibrotic responses induced by transforming growth factor-β (TGF-β), but the precise mechanisms underlying this novel oncogene...

  • TGF-β1 stimulates the release of pre-formed bFGF from renal proximal tubular cells. Jones, Stuart G.; Morrisey, Kimberley; Williams, John D.; Phillips, Aled O. // Kidney International;Jul1999, Vol. 56 Issue 1, p83 

    TGF-β1 stimulates the release of pre-formed bFGF from renal proximal tubular cells. Background.It is now clear that the progression of renal disease is closely correlated to the degree of renal interstitial fibrosis. We have previously demonstrated that the renal proximal tubular epithelial...

  • Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nishita, Michiru; Hashimoto, Minako K. // Nature;2/17/2000, Vol. 403 Issue 6771, p781 

    Discusses the regulation of both cell fate and proliferation during development and tissue maintenance by members of the Wnt and TGF-beta superfamilies. Requirement of the Wnt and TGF-beta superfamily signalling cascades for the establishment of a dorsal signalling center, Spemann's organizer;...

  • Tumor?host interactions in the gallbladder suppress distal angiogenesis and tumor growth: Involvement of transforming growth factor β1. Gohongi, Takeshi; Fukumura, Dai; Boucher, Yves; Yun, Chae-Ok; Soff, Gerald A.; Compton, Carolyn; Todoroki, Takeshi; Jain, Rakesh K. // Nature Medicine;Oct1999, Vol. 5 Issue 10, p1203 

    Angiogenesis inhibitors produced by a primary tumor can create a systemic anti-angiogenic environment and maintain metastatic tumor cells in a state of dormancy. We show here that the gallbladder microenvironment modulates the production of transforming growth factor (TGF)-β1, a...

  • Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Wenger, Christoph; Ellenrieder, Volker; Alber, Burkhard; Lacher, Ulrike; Menke, André; Hameister, Horst; Wilda, Monika; Iwamura, Takeshi; Beger, Hans G; Adler, Guido; Gress, Thomas M // Oncogene;1/28/99, Vol. 18 Issue 4, p1073 

    CTGF: is an immediate early growth responsive gene that has been shown to be a downstream mediator of TGFβ actions in fibroblasts and vascular endothelial cells. In the present study hCTGF was isolated as immediate early target gene of EGF/TGFα in human pancreatic cancer cells by...

  • Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cells. Villanueva, Alberto; García, Carmen; Paules, Ana Belén; Vicente, Mónica; Megías, Montse; Reyes, Germán; de Villalonga, Priam; Agell, Neus; Lluís, Felix; Bachs, Oriol; Capellá, Gabriel // Oncogene;10/15/98, Vol. 17 Issue 15, p1969 

    Resistance to TGF-β1 occurred in pancreatic cancer cells suggesting that inactivation of TGF-β inhibitory signaling pathways may play an important role in human pancreatic cancer. The aim of our study was to determine the presence of alterations in the main putative components of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics